Give the gift of LIFE! Support the Population Research Institute!

Only $106,679 to go!

Topics: Gardasil

PRI Review 2016 (v26, n3) May/June



Lima in the Lead 1 A True Hate Crime 2 Fighting for Life in the West Indies 3 May I Send You This Gift? 4 Mother Angelica’s Legacy  6 From the Countries 7 Abortion is Never the Answer 8 PRI in the News 10 Development Desk 11 Correspondence  12

Read more.




“Gardasil Guards Against Almost Nothing” Merck Researcher Admits



On the morning of October 2nd 2009, one of us (Joan) joined an audience of mostly health professionals and listened as Dr. Diane Harper, the leading international developer of the HPV vaccines, gave a sales pitch for Gardasil. Gardasil, as you may know, is the new vaccine that is supposed to confer protection against but strains of the sexually transmitted Human Papillomavirus (HPV). Dr. Harper came to the 4th International Public Conference on Vaccination to …

Read more.




For the Record



The Population Research Institute, a Catholic-based group questions how the Guttmacher Institute arrives at its statistics. Colin Mason, the media director finds it curious for example that Guttmacher would claim 250,000 illegal abortions in Colombia when according to Mason, the country’s Minister of Health says that just 50 women sought abortions after they became legal. “If there is such an unmet need and they are in a country like Columbia spreading the word about abortion,” …

Read more.




Merck Researcher Admits: Gardasil Guards Against Almost Nothing



On the morning of 2 October 2009, one of us (Joan) joined an audience of mostly health professionals and listened as Dr. Diane Harper, the leading international developer of the HPV vaccines, gave a sales pitch for Gardasil. Gardasil, as you may know, is the new vaccine that is supposed to confer protection against four strains of the sexually transmitted Human Papillomavirus (HPV). Dr. Harper came to the 4th International Public Conference on Vaccination to …

Read more.




Merck Researcher Admits: Guardasil Guards Against Almost Nothing



On the morning of 2 October 2009, one of us (Joan) joined an audience of mostly health professionals and listened as Dr. Diane Harper, the leading international developer of the HPV vaccines, gave a sales pitch for Gardasil.  Gardasil, as you may know, is the new vaccine that is supposed to confer protection against four strains of the sexually transmitted Human Papillomavirus (HPV). Dr. Harper came to the 4th International Public Conference on Vaccination to …

Read more.




What You Should Know about Gardasil (HPV Vaccine)



Gardasil is a new vaccine targeting four strains of Human Papilloma Virus (HPV) generally believed to be the cause of cervical cancer. Two of these strains, HPV-16 and HPV-18 apparently account for about 70 percent of all cervical cancers. However, it is worth noting that the National Cancer Institute in the U.S. says that “direct causation has not been demonstrated.” HPV: What It Is The Human Papilloma Virus (HPV) is a sexually transmitted disease, often …

Read more.




Global Monitor



Scalia & Abortion In a recent speech at the University of Delaware, Supreme Court Justice Antonin Scalia talked about his thoughts on the misinterpretation of the Constitution and how some believe it to support the legality of abortion. Justice Scalia is an “originalist,” meaning he looks for the original meaning of the document rather than viewing it as an ever-changing “living document,” which often offers a more liberal interpretation. He cited the fact that abortion …

Read more.




Notes on the HPV Vaccine



9 March 2007     Vol. 9 / No. 10 Dear Colleague: Why the heavy hand in promoting the HPV vaccine? Steven W. Mosher President Notes on the HPV Vaccine The efforts to force all American girls to receive a new, unnecessary vaccine with unknown long-term side effects seem to have lost much of their momentum for now.  Merck has dropped its campaign to convince states to mandate the vaccine for sixth-grade girls before they can enter …

Read more.




Never miss an update!

Get our Weekly Briefing! We send out a well-researched, in-depth article on a variety of topics once a week, to large and growing English-speaking and Spanish-speaking audiences.